RIVM contributes to the safe use of nanomaterials through research, alerts and policy consultations, and this work is demonstrated in a short informative film.

RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.

Nanotechnology offers improved options for the diagnosis and treatment of cancer.

In a new publication, RIVM indicates scientific challenges in the use of the EU definition for nanomaterial in legislation.

In recent years, an increasing number of applications and products containing or using nanomaterials have become available.